<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004107A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004107</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13897096</doc-number><date>20130517</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>16</main-group><subgroup>24</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>11</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>16</main-group><subgroup>244</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>11</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>4241331</main-classification><further-classification>4241581</further-classification><further-classification>435 696</further-classification><further-classification>435326</further-classification><further-classification>435328</further-classification><further-classification>4353201</further-classification><further-classification>5303873</further-classification><further-classification>5303879</further-classification><further-classification>5303891</further-classification><further-classification>536 2353</further-classification></classification-national><invention-title id="d0e43">ST2 ANTIGEN BINDING PROTEINS</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>61792619</doc-number><date>20130315</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61649147</doc-number><date>20120518</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Amgen Inc.</last-name><address><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>SMITH</last-name><first-name>Dirk E.</first-name><address><city>Bainbridge Island</city><state>WA</state><country>US</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>FOLTZ</last-name><first-name>Ian</first-name><address><city>Burnaby</city><country>CA</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>KING</last-name><first-name>Chadwick T.</first-name><address><city>North Vancouver</city><country>CA</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>LIM</last-name><first-name>Ai Ching</first-name><address><city>Mercer Island</city><state>WA</state><country>US</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>CLARK</last-name><first-name>Rutilio</first-name><address><city>Bainbridge Island</city><state>WA</state><country>US</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>COMEAU</last-name><first-name>Michael R.</first-name><address><city>Bainbridge Island</city><state>WA</state><country>US</country></address></addressbook></inventor><inventor sequence="06" designation="us-only"><addressbook><last-name>KETCHEM</last-name><first-name>Randal R.</first-name><address><city>Snohomish</city><state>WA</state><country>US</country></address></addressbook></inventor><inventor sequence="07" designation="us-only"><addressbook><last-name>SHI</last-name><first-name>Donghui</first-name><address><city>Thousand Oaks</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="08" designation="us-only"><addressbook><last-name>MIN</last-name><first-name>Xiaoshan</first-name><address><city>Burlingame</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="09" designation="us-only"><addressbook><last-name>WANG</last-name><first-name>Zhulun</first-name><address><city>Palo Alto</city><state>CA</state><country>US</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Amgen Inc.</orgname><role>02</role><address><city>THOUSAND OAKS</city><state>CA</state><country>US</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Described herein are compositions and methods related to antigen binding proteins that bind to human ST2, including antibodies. In particular embodiments, the disclosure provides fully human anti-ST2 antibodies and deriviatives and variants thereof. Further provided are nucleic acids encoding such antibodies and antibody fragments, variants, and derivatives. Also, provided are methods of making and using such antibodies including methods of treating and preventing autoimmune and inflammatory disorders.</p></abstract></us-patent-application>